Effects of rituximab therapy on B cell differentiation and depletion
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s10067-020-04996-7.pdf
Reference61 articles.
1. Salles G, Barrett M, Foà R, Maurer J, O'Brien S, Valente N, Wenger M, Maloney DG (2017) Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience. Adv Ther 34(10):2232–2273. https://doi.org/10.1007/s12325-017-0612-x
2. Pavanello F, Zucca E, Ghielmini M (Feb. 2017) Rituximab: 13 open questions after 20years of clinical use. Cancer Treat Rev 53:38–46. https://doi.org/10.1016/j.ctrv.2016.11.015
3. Lee I et al (2019) Comparisons of 131I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma. Ann Nucl Med. https://doi.org/10.1007/s12149-019-01401-5
4. García-Muñoz R et al (2019) Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study. Br J Haematol. https://doi.org/10.1111/bjh.16227
5. Cylwik B, Gruszewska E, Gindzienska-Sieskiewicz E, Kowal-Bielecka O, Chrostek L (2019) Serum profile of transferrin isoforms in rheumatoid arthritis treated with biological drugs. Clin Biochem. https://doi.org/10.1016/j.clinbiochem.2019.10.005
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of pediatric rheumatologists’ approach to rituximab use: a questionnaire study;European Journal of Pediatrics;2024-06-26
2. ÇÖZÜLMÜŞ HEPATİT B ENFEKSİYONLU VE ROMATİZMAL HASTALIĞI OLAN BİREYLERDE RİTUKSİMAB KULLANIMININ HEPATİT B REAKTİVASYONU ÜZERİNE ETKİSİ: TEK MERKEZLİ BİR ÇALIŞMA;İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi;2024-06-20
3. A new perspective on therapies involving B-cell depletion in autoimmune diseases;Molecular Biology Reports;2024-05-08
4. The role of B cells in systemic sclerosis;The Journal of Dermatology;2024-02-06
5. Distribution of multi-level B cell subsets in thymoma and thymoma-associated myasthenia gravis;Scientific Reports;2024-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3